Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. The company offers VolparaEnterprise software, a cloud based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements. It also offers VolparaDose that computes woman's personal X-ray dose based on specific breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; and VolparaPositioning that automatically assesses the positioning of the patient, as well as VolparaServer products. The company operates in the Asia Pacific, Europe, the Middle East, Africa, the United States, and Canada. The company was formerly known as matakina Technology Ltd. Volpara Health Technologies Limited was founded in 2009 and is based in Wellington, New Zealand.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Volpara Health Tech (ASX:VHT) Frequently Asked Questions
What is Volpara Health Tech's stock symbol?
Volpara Health Tech trades on the ASX under the ticker symbol "VHT."
Has Volpara Health Tech been receiving favorable news coverage?
News headlines about VHT stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Volpara Health Tech earned a coverage optimism score of 1.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Volpara Health Tech.
Who are some of Volpara Health Tech's key competitors?
Some companies that are related to Volpara Health Tech include Integral Diagnostics (IDX), Akumin (AKU), Exagen (XGN), Renalytix Ai (RENX), Profound Medical (PRN), Senseonics (SENS), Palatin Technologies (PTN), Oncosil Medical (OSL), MaxCyte (MXCT), Yourgene Health (YGEN), Lexagene (LXG), BARD1 Life Sciences (BD1), Sernova (SVA), GeneNews (GEN) and Oncimmune (ONC).
What other stocks do shareholders of Volpara Health Tech own?
Who are Volpara Health Tech's key executives?
Volpara Health Tech's management team includes the folowing people:
- Dr. Ralph Highnam, CEO, Chief Scientist, Exec. Director & Member of Scientific Board
- Mr. Craig Hadfield, CFO & Joint Company Sec.
- Mr. David Murray Ph.D., Chief Technology Officer
- Mr. Mark Koeniguer, Chief Commercial Officer & Pres of USA
- Mr. Julian Marshall, Chief Product Officer
What is Volpara Health Tech's stock price today?
One share of VHT stock can currently be purchased for approximately A$1.82.
How big of a company is Volpara Health Tech?
What is Volpara Health Tech's official website?
MarketBeat Community Rating for Volpara Health Tech (ASX VHT)
MarketBeat's community ratings are surveys of what our community members think about Volpara Health Tech and other stocks. Vote "Outperform" if you believe VHT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VHT will underperform the S&P 500 over the long term. You may vote once every thirty days.
